Wein Matthew 4
4 · Metagenomi Therapeutics, Inc. · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
Metagenomi (MGX) GC Matthew Wein Sells 558 Shares
What Happened
Matthew Wein, Metagenomi's General Counsel, Compliance Officer and Corporate Secretary, had 558 shares of common stock sold on June 5, 2026 at $1.30 per share, generating proceeds of $725. According to the filing, the sale was an automatic disposition to satisfy tax withholding on vested restricted stock units and not a volitional open-market trade.
Key Details
- Transaction date and price: June 5, 2026 — sale of 558 shares at $1.30 each (total $725).
- Shares owned after transaction: not specified in the provided summary.
- Footnotes: F1 — shares were automatically sold to satisfy tax withholding on RSU vesting (from RSUs granted April 1, 2024 and April 1, 2025); F2 — filing notes inclusion of 1,500 shares acquired under the company ESPP on May 29, 2026.
- Filing timeliness: Form 4 filed June 10, 2026 for a June 5 transaction, which is outside the standard two-business-day filing window (i.e., filed late).
Context
Tax-withholding sales on RSU vesting are routine corporate actions and are generally not interpreted as a personal sentiment indicator. The sale size here is very small ($725) and was reported as automatic to cover taxes rather than a discretionary divestiture.
Insider Transaction Report
Form 4
Wein Matthew
See Remarks
Transactions
- Sale
Common Stock
[F1][F2]2026-06-05$1.30/sh−558$725→ 126,491 total
Footnotes (2)
- [F1]These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.
- [F2]Includes 1,500 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 29, 2026.
Signature
/s/ Matthew L. Wein|2026-06-10